Início › Câncer Endometrial › Califórnia

Ensaios clínicos de Câncer Endometrial em Califórnia

73 estudos para Câncer Endometrial estão buscando participantes em locais em Califórnia.

Cidades em Califórnia

Texto oficial do estudo (Inglês)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

PCR Oncology, Arroyo Grande
Mercy Cancer Center - Carmichael, Carmichael
Mercy San Juan Medical Center, Carmichael
e mais 15

RecrutandoFase 2

Todas as idades · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05564377

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

University of San Diego Moores Cancer Center, La Jolla
UCLA Jonsson Comprehensive Cancer Center, Los Angeles
USC Norris Comprehensive Cancer Center, Los Angeles

RecrutandoFase 1/2

Idades 12 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT04585750

Distance-Based Exercise to Preserve Function and Prevent Disability

Kaiser Permanente Dublin, Dublin
Kaiser Permanente-Fremont, Fremont
Kaiser Permanente Fresno Orchard Plaza, Fresno
e mais 10

Recrutando

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07059884

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Mercy Cancer Center - Carmichael, Carmichael
Mercy San Juan Medical Center, Carmichael
Kaiser Permanente Dublin, Dublin
e mais 26

RecrutandoFase 3

Idades 18 e acima · Mulheres · Atualizado em 2 de out. de 2026 · NCT07198074

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

City of Hope - Duarte Cancer Center, Duarte

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06760819

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

University of California - Los Angeles, Los Angeles

RecrutandoFase 1

Idades 19 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06586957

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

City of Hope, Duarte

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06172478

DESTINY-PANTUMOUR04

Research Site, San Diego

RecrutandoEstudo observacional

Idades de 18 a 130 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07124000

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

Research Site, Duarte
Research Site, Los Angeles
Research Site, Newport Beach

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06218914

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

City of Hope Comprehensive Cancer Center, Duarte
The City of Hope Orange County Lennar Foundation Cancer Center, Irvine
Chao Family Comprehensive Cancer Center, Orange

RecrutandoFase 1/2

Idades 18 e acima · Mulheres · Atualizado em 24 de set. de 2026 · NCT04590326

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

Cedars-Sinai Medical Center, Los Angeles
Huntington Memorial Hospital, Pasadena
Sutter Medical Center Sacramento, Sacramento

RecrutandoFase 2

Idades 18 e acima · Mulheres · Atualizado em 24 de set. de 2026 · NCT05640999

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

Kivu Trial Site, Santa Monica

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT07229313

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Research Site, Los Angeles
Research Site, Santa Rosa

RecrutandoFase 2

Idades de 18 a 130 · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT05489211

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

UC IRVINE Health, Orange
UC Davis Comprehensive Cancer Center, Sacramento
Stanford Cancer Institute, Stanford

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06128551

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

City of Hope, Duarte
University of California, Los Angeles (UCLA), Santa Monica
Stanford University Medical Center, Stanford

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07114601

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

California Research Institute (CRI), Los Angeles

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07262619

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Beverly Hills Cancer Center, Beverly Hills
City of Hope Cancer Center, Duarte
University of California Irvine Medical Center, Orange
e mais 1

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 21 de set. de 2026 · NCT05983432

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

CHAO Family Comprehensive Cancer Center and Ambulatory Care ( Site 5014), Irvine
University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 6020), Orange
Sansum Clinic (Ridley Tree) ( Site 8007), Solvang
e mais 1

RecrutandoFase 3

Idades 18 e acima · Mulheres · Atualizado em 17 de set. de 2026 · NCT06952504

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

City of Hope, Duarte
City of Hope, Irvine, Irvine

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT07109726

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

University of California, San Diego, La Jolla
Hoag Memorial Hospital Presbyterian, Newport Beach
Redwood City, Redwood City

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT05059444

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

Research Site, Santa Monica
Research Site, Santa Rosa

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 11 de set. de 2026 · NCT05123482

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

City of Hope, Duarte
START - Los Angeles, Los Angeles
Cedars Sinai, Los Angeles
e mais 1

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 10 de set. de 2026 · NCT06293898

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

Kaiser Permanente SoCal, Irvine
CPMC Research Institute, San Francisco

RecrutandoFase 3

Idades 18 e acima · Mulheres · Atualizado em 9 de set. de 2026 · NCT07166094

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT06400472

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Research Site, Duarte
Research Site, Irvine
Research Site, La Jolla

RecrutandoFase 3

Idades 18 e acima · Mulheres · Atualizado em 3 de set. de 2026 · NCT06989112

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

UC San Diego Moores Cancer Center, La Jolla
University of Southern California, Los Angeles

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT07216105

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

UC San Diego Moores Cancer Center, San Diego

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 27 de ago. de 2026 · NCT07227168

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

START Los Angeles, Los Angeles

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 26 de ago. de 2026 · NCT07383506

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

City of Hope, Duarte
Stanford, Palo Alto
University of California, San Francisco

RecrutandoFase 1

Idades 15 e acima · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT06276491

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Children's Hospital Los Angeles, Los Angeles
Children's Hospital of Orange County, Orange
UCSF Medical Center-Mission Bay, San Francisco

RecrutandoFase 1/2

12 Months – 30 Years · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT04851119

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

Hoag Family Cancer Institute, Newport Beach

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 21 de ago. de 2026 · NCT06774963

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

Research Site, Duarte
Research Site, Irvine

RecrutandoFase 1/2

Idades de 18 a 130 · Todos os sexos · Atualizado em 21 de ago. de 2026 · NCT05797168

A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)

Valkyrie Clinical Trials, Los Angeles

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 21 de ago. de 2026 · NCT07306559

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

City of Hope National Medical Center, Duarte
UC San Diego Moores Cancer Center, La Jolla
Cedars Sinai Medical Center, Los Angeles
e mais 4

RecrutandoFase 2

Idades 18 e acima · Mulheres · Atualizado em 21 de ago. de 2026 · NCT05548296

Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers

University of California at Los Angeles, Los Angeles

Recrutando

Idades 18 e acima · Mulheres · Atualizado em 20 de ago. de 2026 · NCT06538337

A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

START - Los Angeles, Los Angeles

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 18 de ago. de 2026 · NCT07470853

FOG-001 in Locally Advanced or Metastatic Solid Tumors

University of California, Los Angeles (UCLA), Los Angeles
Stanford Cancer Institute, Stanford University, Palo Alto
University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco
e mais 1

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT05919264

A Study of PHST001 in Advanced Solid Tumors

Precision NextGen Oncology & Research Center, Beverly Hills
USC Norris Comprehensive Cancer Center, Los Angeles
Stanford University School of Medicine, Palo Alto

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 12 de ago. de 2026 · NCT06840886

A Study of MGC026 in Participants With Advanced Solid Tumors

The Angeles Clinic and Research Institute, Los Angeles

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 11 de ago. de 2026 · NCT06242470

A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer

City of Hope at Arcadia, Arcadia
City of Hope Medical Center, Duarte
City of Hope at Seacliff, Huntington Beach
e mais 8

Recrutando

Idades 18 e acima · Mulheres · Atualizado em 10 de ago. de 2026 · NCT07741968

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.